ÀÚ·á¼³¸í
I. ¼ ·Ð , II. Factors determining the teratogenic effect of a drug, 1. Teratogenic potential of an agent, 2. Gestational Age, 3. Dose & Duration of exposure, 4. Genetic susceptibility, III. ÀÓ½ÅÁß ¿µ¾çÁ¦ , IV. °¨±â¾à, V. Ç×»ýÁ¦, 1. ÀϹÝÀû ¼¼±Õ °¨¿°, 2. °áÇÙ, 3. Áø±Õ °¨¿°, 4. Trichomonas °¨¿°, VI. ÁøÅëÁ¦ ¹× ¼Ò¿°Á¦, 1. Nonsteroidal anti-inflamatory agents(NSAIDs), 2. Corticosteroids, VII. ¸¶ÃëÁ¦ , VIII. Ç׿À½ÉÁ¦, IX. ¼Òȱâ°è ¾à¹°, X. ±âȣǰ, XI. ¹æ»ç¼± °Ë»ç, XII. ÀÚ±â°ø¸í¿µ»ó(MRI) , XIII. ÀüÀÚÆÄ, XIV. °á ·Ð, , FileSize : 142K
¸ñÂ÷/Â÷·Ê
I. ¼ ·Ð
II. Factors determining the teratogenic effect of a drug
1. Teratogenic potential of an agent
2. Gestational Age
3. Dose & Duration of exposure
4. Genetic susceptibility
III. ÀÓ½ÅÁß ¿µ¾çÁ¦
IV. °¨±â¾à
V. Ç×»ýÁ¦
1. ÀϹÝÀû ¼¼±Õ °¨¿°
2. °áÇÙ
3. Áø±Õ °¨¿°
4. Trichomonas °¨¿°
VI. ÁøÅëÁ¦ ¹× ¼Ò¿°Á¦
1. Nonsteroidal anti-inflamatory agents(NSAIDs)
2. Corticosteroids
VII. ¸¶ÃëÁ¦
VIII. Ç׿À½ÉÁ¦
IX. ¼Òȱâ°è ¾à¹°
X. ±âȣǰ
XI. ¹æ»ç¼± °Ë»ç
XII. ÀÚ±â°ø¸í¿µ»ó(MRI)
XIII. ÀüÀÚÆÄ
XIV. °á ·Ð
º»¹®/³»¿ë
1960³â´ëÀÇ "thalidomide catastrophe"·Î ÀÓ½ÅÁß »ê¸ðÀÇ ¾à¹°º¹¿ëÀÌ Å¾ƿ¡ ½É°¢ÇÑ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ´Ù´Â Áõ°Å°¡ Á¦½ÃµÈ ÀÌÈÄ ÀÓ½ÅÁß¿¡´Â ¾î¶°ÇÑ ¾à¹°µµ žƿ¡ ÇØ°¡ µÈ´Ù°í »ý°¢ÇØ ¿Ô°í ÃÖ±Ù±îÁöµµ ÀÌ·¯ÇÑ ÀϹÝÀûÀÎ »ý°¢Àº º¯ÈÇÏÁö ¾Ê´Â °ÍÀ¸·Î º¸ÀδÙ. ½ÇÁ¦ ÀÓ½ÅÁßÀÇ ¾à¹°Åõ¿©°¡ ±× »ê¸ð ¶Ç´Â žƿ¡ ¾î¶°ÇÑ ¿µÇâÀ» ¹ÌÄ¡´ÂÁö¸¦ °áÁ¤ÇÏ´Â °ÍÀº ¸Å¿ì Èûµç ÀÏÀÌ¸ç ¾ÆÁ÷±îÁöµµ žƿ¡ ´ëÇÑ À§ÇØ ¿©ºÎ°¡ È®ÀÎµÈ ¾à¹°Àº ±×¸® ¸¹Áö ¾Ê´Ù.
»ê¸ðµéÀº ¿©·¯ ÀÌÀ¯·Î ¾à¹°µé(ÇѾàÀ» Æ÷ÇÔÇÑ)À» º¹¿ëÇÏ°Ô µÇ¸ç ÀÌ·Î ÀÎÇØ °í¹ÎÇÏ´Ù À¯»êÀ̶ó´Â ±Ø´ÜÀûÀÎ ¹æ¹ýÀ» ¼±ÅÃÇÏ´Â °æ¿ìµµ ÀÖ´Ù. World Health OrganizationÀÇ ¹ßÇ¥¿¡ µû¸£¸é Àü¼¼°èÀûÀ¸·Î 86%ÀÇ »ê¸ð°¡ ÀÓ½ÅÁß Æò±Õ 2.9 Á¾·ùÀÇ ¾à¹°À» º¹¿ëÇÑ´Ù°í ÇÑ´Ù(Collaborative Group on drug use in pregnancy, 1991). µû¶ó¼ ÀÓ»ó¿¡¼ »ê¸ð¸¦ Á÷Á¢ ´Ù·ç´Â »êºÎÀΰú ÀÇ»ç´Â °¢Á¾ ¾à¹°°ú ±× ±âÀü¿¡ ´ëÇÑ Ç³ºÎÇÑ Áö½ÄÀ» °®°í ÀÖ¾î¾ß Çϸç À̸¦ ÅëÇÏ¿© ¶æÇÏÁö ¾Ê°Ô ¾à¹°À» º¹¿ëÇÏ°Ô µÇ¾î °ÆÁ¤Çϰí ÀÖ´Â »ê¸ð¿¡°Ô ÀûÀýÇÑ Á¶¾ðÀ¸·Î À§Çذ¡ µÇ´Â ¾à¹°°ú ±×·¸Áö ¸øÇÑ °ÍÀ» ±¸ºÐÇØÁÙ ¼ö ÀÖ¾î¾ß ÇÑ´Ù. »Ó¸¸ ¾Æ´Ï¶ó »ê¸ð°¡ ¾î¶² ÁúȯÀ̳ª ±× Áõ¡¦(»ý·«)